Disorders of immunological balance between Th1 and Th2 cells and the role of chosen cytokines in atopic dermatitis;Zaburzenia równowagi immunologicznej subpopulacji limfocytów Th1 i Th2 oraz rola ich wybranych cytokin w atopowym zapaleniu skóry

Postepy Dermatologii I Alergologii

Volumn 23, Issue 2, 2006, Pages 88-93

  Dzienis, Katarzyna ^a   Tryniszewska, Elzbieta ^a   Kaczmarski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Atopic dermatitis; Cytokines; T helper cells subpopulation

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

APOPTOSIS; ATOPIC DERMATITIS; CELL LEVEL; DISEASE ACTIVITY; GROWTH INHIBITION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 33744492848     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Wanat-Krzak M, Kurzawa R. Atopowe zapalenie skóry - etiopatogeneza, diagnostyka i leczenie. Alergologia i putmonologia wieku dzieciecego. Klinika Pediatryczna 2002; 10: 237-244.
2. Czarnecka-Operacz M, Silny W. Atopowe zapalenie skóry - aktualny stan wiedzy. Post Dermatol Alergol 2002, 3: 152-60.
3. Silny W, Czarnecka-Operacz M. Atopowe zapalenie skóry - udział limfocytów T i komórek Langerhansa w rozwoju zmian skórnych. Alergia Astma Immunologia 2000; 5 (suppl. 2): 15-20.
4. Leung DY. Pathogenesis of atopic dermatits. J Allergy Clin Immunol 1999; 104: 99-108.
5. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-24.
6. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-7.
7. Novak N, Bieber T. Allergic and nonallergic forms of atopic dermatitis. J Allergy Clin Immunol 2003; 112: 252-62.
8. Gliński W. Patogeneza atopowego zapalenia skóry. Post Dermatol Alergol 2001; 2: 75-9.
9. Silny W. Etiopatogeneza atopowego zapalenia skóry. Postepy w alergologii II, Medpress 1997: 60-4.
10. Silny W, Czarnecka-Operacz M, Piotrowski M. Komórki Langerhansa i ich prawdopodobny udział w patomechanizmie atopowego zapalenia skóry. Przegl Derm 1996; 83: 133-9.
11. Novak N, Bieber T, Kraft S. Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis. Curr Allergy Asthma Rep 2004; 4: 263-39.
12. Kuna P. Atopowe zapalenie skóry. W: Immunologia kliniczna. Kowalski M (red.). Mediton 2000: 199-240.
13. Machura E, Halkiewicz F, Mazur B, et al. Subpopulacje limfocytów krwi obwodowej u dzieci z zespołem atopowego zapalenia skóry. Alergia Astma Immunologia 2002; 7: 205-10.
14. Saurat JH. Eczema in primary immune-deficiences clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol (Stockh) 1985; 114: 125-8.
15. Berard F, Marty JP, Nicolas JF. Przenikanie alergenów przez skóre. Dermatologia 2004; 5: 28-38.
16. Werner Y, Lindberg M. Transepidermal water toss in dry and clinically normal skin in patients with atopic dermatits. Acta Dermat Venereol 1987; 116: 525-30.
17. Józefowicz G, Kuna P. Rola limfocytów Th1 i Th2 w chorobach atopowych. Alergia Astma Immunologia 1998; 3: 76-80.
18. Spergel JM, Mizoguchi E, Oettgen H, et al. Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999; 103: 1103-11.
19. Antunez C, Torres MJ, Mayorga C, et al. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen + T cells from patients with acute or chronic atopic dermatitis. Clin Exp Allergy 2004; 34: 559-66.
20. Teraki Y, Hotta T, Shiohara T. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokines- producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis. Br J Dermatol 2000; 143: 373-8.
21. Uchida T, Suto H, Ra C, et al. Preferential expression of Th2-type chemokine and its receptor in atopic dermatitis. International Immunology 2002; 14: 1431-8.
22. Campbell J, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400: 776.
23. Vestergaard C, Yoneyama H, Murai M, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999; 104: 1097-105.
24. Zingoni A, Soto H, Hedrick J, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1. J Immunol 1998; 161: 547-51.
25. Schuval S, Bonagura V, Saperstein J. Atopic disease in HIV-infected children. J Allergy Clin Immunol 1995; 95: 247-52.
26. Shirakawa T, Enamoto T, Shimazu S, et al. The inverse association between tuberculin response and atopic disorder. Science 1997; 275: 77-9.
27. Herrick CA, Xu L, McKenzie ANJ, et al. IL-13 is necessary, not simply sufficient, for epicutaneousty induced Th2 responses to soluble protein antigen. J Immunol 2003; 170: 2488-95.
28. Laouini D, Alenius H, Bryce P, et al. IL-10 is critical for Th2 responses in a murine model of atopic dermatitis. J Clin Invest 2003; 112: 1058-66.
29. Ong PY, Hamid QA, Travers JB, et al. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 2002; 168: 505-10.
30. Katsunuma T, Kawahara H, Yuki K, et al. Impaired interferon-γ production in a subset population of severe atopic dermatitis. Int Arch Allergy lmmunol 2004; 134: 240-7.
31. Tang ML, Kemp AS. Production and secretion of interferon gamma (IFN-gamma) in children with atopic dermatitis. Clin Exp Immunol 1994; 95: 66-72.
32. Jung T, Lack G, Schauer U, et al. Decreased frequency of interferon-gamma- and interleukin-2-producing cells in patients with atopic dermatitis measured at single cell level. J Allergy Clin Immunol 1995; 96: 515-27.
33. Jung T, Moessner R, Diechoff K, et al. Mechanisms of deficient interferon-gamma production in atopic dermatitis. Clin Exp Allergy 1999; 29: 912-19.
34. Campbell DE, Fryga AS, Bol S, Kemp AS. Intracellular interferon-gamma (INF-gamma) production in normal children and children with atopic dermatitis. Clin Exp Immunol 1999; 115: 377-82.
35. Machura E, Mazur B, Grzywna E, et al. Ekspresja CD23 na limfocytach B krwi obwodowej i steżenie cytokin IL-4, IL-10, IL-12 u dzieci z zespołem atopowego zapalenia skóry. Alergia Astma Immunotogia 2004; 9: 39-44.
36. Kedzierska A, Kapińska-Mrowiecka M, Czubak-Macugowska M i wsp. Produkcja cytokin typu Th1 i Th2 przez aktywowane jednojadrzaste komórki krwi obwodowej (PBMC) u pacjentów z atopowym zapaleniem skóry - zwiazek ze stanem klinicznym i kotonizacja skóry przez Staphylococcus aureus. Post Dermatol Alergol 2004; 4: 180-9.
37. Takahashi T, Sasaki Y, Hama K, et al. Production of IL-4, IL-2, IFN-γ, and TNF-α by peripheral blood mononuclear cells of patients with atopic dermatitis. J Dermatol Sci 1992; 3: 172-80.
38. Yoshino T, Asada H, Sano S, et al. Impaired responses of peripheral blood mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis: a role of T cell apoptosis. J Invest Dermatol 2000; 114: 281-8.
39. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriaris, skin prevents induction of innate immune response genes. J Immunol 2003; 171: 3262-9.
40. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interlukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
41. Boehm U, Klamp T, Groot U, et al. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749-95.
42. Tang ML, Varigos G, Kemp AS. Reduced interferon-gamma (IFN-gamma) secretion with increased IFN-gamma mRNA expression in atopic dermatitis: Evidence for a post-trascriptional defect. Clin Exp Immunol 1994; 97: 483-90.
43. Grewe M, Gyufko K, Schopf E, et al. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343: 25-6.
44. Shimada Y, Takehara K, Sato S. Both Th2 I Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Derm Sci 2004; 34: 201-8.
45. Hamid Q, Naseer T, Minshall EM, et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98: 225-31.
46. German T, Guckes S, Bongartz M, et al. Administration of IL-12 during ongoing immune responses fails to permanently suppress can even enhance the synthesis of antigen-specific IgE production. Int Immunol 1995; 7: 1649-57.
47. Sampson HA. Atopic dermatitis: immunological mechanisns in relation to phenotype. Pediatr Allergy Immunol 2001; 12 (Suppl. 14): 62-8.
48. El-Mezayen RE, Matsumoto T. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis. Clin Immunol 2004; 111: 61-8.
49. Wong CK, Ho CY, Ko FW, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (INF-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001; 125: 177-83.
50. Tanaka H, Miyazaki N, Ohashi K, et al. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol 2001; 107: 331-6.
51. Tanaka T, Tsutsui H, Yoshimoto T, et al. Interleukin-18 is elevated in sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int Arch Allergy Immunol 2001; 125: 236-40.
52. Konishi H, Tsutsui H, Murakami T, et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Immunology (PNAS) 2002; 99: 11340-5.
53. El-Mezzein R, Matsumoto T, Nomiyama H, et al. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 2001; 126: 193-8.
54. Yoshimoto T, Okamura H, Tagawa I, et al. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc Natl Acad Sci USA 1997; 94: 3948-53.
55. Ahn HJ, Maruo S, Tomura M, et al. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ. J Immunol 1997; 159: 2125-31.
56. Hoshino T, Yagita H, Ortaldo JR, et al. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol 2000; 30:1998-2006.
57. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
58. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
59. Varadhachary AS, Peter ME, Perdow SN, et al. Selective up-regulation of phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. J Immunol 1999; 163: 4772-9.
60. Scaffidi C, Kirchhof S, Krammer PH, et al. Apoptosis signaling in lymphocytes. Curr Opin Immunol 1999; 11: 277-85.
61. Akdis M, Trautmann A, Klunker S, et al. T helper (Th)2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/ effector Th1 cells. FASEB J 2003; 17: 1026-35.
62. Zhang X, Brunner T, Carter L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/ FasL-mediated apoptosis. J Exp Med 1997; 185: 1837-49.
63. Zhang XR, Zhang LY, Devadas S, et al. Reciprocal expression of TRIAL and CD95L in Th1 and Th2 cells: role of apoptosis in T-helper subset differentiation. Cell Death Differ 2003; 10: 203-10.